Bone mineral density assessment using the EOS low-dose X-ray device: a feasibility study.

Area of Science:

• Orthopedics
• Radiology
• Biomedical Engineering

Background:

• Assessing bone mineral density (BMD) is crucial for predicting bone strength, especially in osteoporosis.
• Existing methods may involve higher radiation doses or separate assessments for geometry and density.
• The EOS system offers low-dose, 3D imaging capabilities.

Purpose of the Study:

• To evaluate the accuracy and reproducibility of the EOS system for ex vivo bone mineral density (BMD) assessment.
• To compare the EOS system's densitometry performance against a established Hologic device.

Main Methods:

• The European Spine Phantom (ESP) was scanned ten times with both EOS and Hologic devices.
• Ex vivo vertebrae (n=41) were scanned to assess BMD accuracy and reproducibility.
• Accuracy was determined by systematic and random errors; reproducibility by coefficient of variation.

Main Results:

• The EOS system demonstrated an accuracy below 5.2%, outperforming the Hologic system's 7.2% accuracy under identical conditions.
• EOS-derived BMDs were significantly higher than Hologic BMDs but showed strong correlation.
• The reproducibility of EOS BMD assessment was excellent, with a coefficient of variation of 0.95%.

Conclusions:

• The EOS system is accurate for ex vivo bone mineral density (BMD) assessment.
• Its high accuracy and reproducibility suggest potential for predicting vertebral strength.
• This low-dose system could enhance osteoporosis management by combining geometric and densitometric evaluation.